The bumpy road to treating multiple sclerosis with stem cells
Mixed messages surrounding their clinical benefits threatened the legitimacy of stem cell therapies for multiple sclerosis, but there is still plenty of promise.
Mixed messages surrounding their clinical benefits threatened the legitimacy of stem cell therapies for multiple sclerosis, but there is still plenty of promise.